<--- Back to Details
First PageDocument Content
Solute carrier family / Transport proteins / Transport phenomena / Electrophysiology / Sodium-glucose transport proteins / Membrane potential / SLC5A1 / Cotransporter / Active transport / Biology / Cell biology / Integral membrane proteins
Solute carrier family
Transport proteins
Transport phenomena
Electrophysiology
Sodium-glucose transport proteins
Membrane potential
SLC5A1
Cotransporter
Active transport
Biology
Cell biology
Integral membrane proteins

2405 Biophysical Journal Volume 69 December[removed]

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 1,66 MB

Share Document on Facebook

Similar Documents

Endocrine system / Chemistry / Gastroenterology / Sitagliptin / Incretin / SLC5A2 / Astellas Pharma / Diabetes management / Sodium-glucose transport proteins / Dipeptidyl peptidase-4 inhibitors / Anti-diabetic drugs / Amides

Microsoft Word - final_150414_e.docx

DocID: 13VvB - View Document

Biology / SLC5A2 / Diabetes mellitus type 1 / Diabetes mellitus / Anti-diabetic medication / Insulin / Sodium-glucose transport proteins / Lexicon Pharmaceuticals / Diabetes / Endocrine system / Medicine

For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A

DocID: M3m3 - View Document

Medicine / Solute carrier family / Autoimmune diseases / Colitis / Co-transport / Ulcerative colitis / Cotransporter / Sodium-glucose transport proteins / Incretin / Health / Transport phenomena / Gastroenterology

MISSISSIPPI DIVISION OF MEDICAID Pharmacy & Therapeutics Committee Woolfolk Building Conference Center East, Room 145 Jackson, MS[removed]February 10, 2015

DocID: LPQH - View Document

Biology / SLC5A2 / Diabetes mellitus / Insulin / Anti-diabetic medication / Metformin / Sodium-glucose transport proteins / Glycated hemoglobin / Diabetes management / Diabetes / Endocrine system / Medicine

For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the European Association for the Study of Diabetes Meeting TOKYO, September

DocID: Jky3 - View Document

Medicine / Daiichi Sankyo / Diabetes mellitus / Glycated hemoglobin / Canagliflozin / Sodium-glucose transport proteins / SLC5A2 / Diabetes / Endocrine system / Health

September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg

DocID: FycR - View Document